SCHEMBL2470902

SCHEMBL2470902

C=CCNCCc1ccc(N(C)S(=O)(=O)c2ccc(OC(F)(F)F)cc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 1/20 0.49
HDAC4 P56524 1/20 0.49
HDAC1 Q13547 1/20 0.49
HDAC7 Q8WUI4 1/20 0.49
HDAC2 Q92769 1/20 0.49
HDAC10 Q969S8 1/20 0.49
HDAC11 Q96DB2 1/20 0.49
HDAC8 Q9BY41 1/20 0.49
HDAC6 Q9UBN7 1/20 0.49
HDAC9 Q9UKV0 1/20 0.49
HDAC5 Q9UQL6 1/20 0.49
ALDH1A1 P00352 6/20 0.48
HPGD P15428 1/20 0.48
SERPINE1 P05121 2/20 0.47
CNR2 P34972 1/20 0.46
LMNA P02545 2/20 0.46
MAPT P10636 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.43
MCOLN3 Q8TDD5 1/20 0.43
NR3C1 P04150 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4923250 0.99 HDAC3 (0.48) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL2466067 0.87 SERPINE1 (0.51) SERPINE1CNR2LMNANR3C1HTT
Hydrochloric Acid SCHEMBL4920488 0.86 SERPINE1 (0.50) SERPINE1CNR2LMNANR3C1HTT
SCHEMBL2470132 0.81 ALDH1A1 (0.44) ALDH1A1HPGDCNR2LMNAMAPT
SCHEMBL2472519 0.80 HDAC1 (0.50) HDAC3HDAC4HDAC1HDAC7HDAC2
Hydrochloric Acid SCHEMBL4922303 0.80 ALDH1A1 (0.43) ALDH1A1HPGDCNR2LMNAMAPT
Hydrochloric Acid SCHEMBL4922816 0.79 HDAC1 (0.49) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL2474733 0.72 HTR6 (0.47) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL4575930 0.69 SCN8A (0.47) ALDH1A1LMNAMAPTSMN1; SMN2KMT2A
SCHEMBL2470396 0.67 CNR2 (0.49) ALDH1A1CNR2MAPTKMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2371814-A1 Aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor Abbott GmbH & Co. KG (DE) 2011-10-05 EP disclosed